We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01380600
First Posted: June 27, 2011
Last Update Posted: January 8, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Samsung Medical Center
Information provided by (Responsible Party):
SillaJen, Inc. ( Jennerex Biotherapeutics )
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)